Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The muscarinic M(4) receptor is the functionally predominant subtype in rat and mouse striatum as demonstrated using [(35)S] GTPγS binding.

Chapman KL, Vaswani D, Hendry N, Langmead CJ, Kew JN, Watson JM.

Eur J Pharmacol. 2011 Feb 10;652(1-3):1-6. doi: 10.1016/j.ejphar.2010.10.079. Epub 2010 Nov 30.

PMID:
21114972
3.

Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.

Pilar-Cuéllar F, Paniagua MA, Mostany R, Pérez CC, Fernández-López A.

J Chem Neuroanat. 2005 Oct;30(2-3):119-28.

PMID:
16095872
4.

Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.

Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P.

J Pharmacol Exp Ther. 1999 Jan;288(1):164-70.

5.
6.

Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).

Olianas MC, Maullu C, Adem A, Mulugeta E, Karlsson E, Onali P.

Br J Pharmacol. 2000 Oct;131(3):447-52.

7.

Segment-dependent activation of muscarinic acetylcholine receptor-mediated [35S]Guanosine-5'-O-(gamma-thiotriphosphate) binding in airway tissue membranes.

Hajek P, Ungemach FR, Abraham G.

Pharmacology. 2009;83(4):247-58. doi: 10.1159/000209254. Epub 2009 Mar 19.

PMID:
19295255
8.
10.

Functional activation of G-proteins coupled with muscarinic acetylcholine receptors in rat brain membranes.

Odagaki Y, Kinoshita M, Toyoshima R.

J Pharmacol Sci. 2014;125(2):157-68. Epub 2014 May 20.

12.

Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.

Lazareno S, Birdsall B, Fukazawa T, Gharagozloo P, Hashimoto T, Kuwano H, Popham A, Sugimoto M, Birdsall NJ.

Life Sci. 1999;64(6-7):519-26.

PMID:
10069518
14.

Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.

Watson J, Brough S, Coldwell MC, Gager T, Ho M, Hunter AJ, Jerman J, Middlemiss DN, Riley GJ, Brown AM.

Br J Pharmacol. 1998 Dec;125(7):1413-20.

15.

Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.

Salah-Uddin H, Scarr E, Pavey G, Harris K, Hagan JJ, Dean B, Challiss RA, Watson JM.

Neuropsychopharmacology. 2009 Aug;34(9):2156-66. doi: 10.1038/npp.2009.41. Epub 2009 Apr 29.

16.

Autoradiographic analysis of dopamine receptor-stimulated [(35)S]GTPgammaS binding in rat striatum.

He L, Di Monte DA, Langston JW, Quik M.

Brain Res. 2000 Dec 1;885(1):133-6.

PMID:
11121540
18.

Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.

Salah-Uddin H, Thomas DR, Davies CH, Hagan JJ, Wood MD, Watson JM, Challiss RA.

J Pharmacol Exp Ther. 2008 Jun;325(3):869-74. doi: 10.1124/jpet.108.137968. Epub 2008 Mar 5.

19.

Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.

Odagaki Y, Toyoshima R.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1304-12. Epub 2006 Jul 7.

PMID:
16824659
20.

Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.

Leach K, Loiacono RE, Felder CC, McKinzie DL, Mogg A, Shaw DB, Sexton PM, Christopoulos A.

Neuropsychopharmacology. 2010 Mar;35(4):855-69. doi: 10.1038/npp.2009.194. Epub 2009 Nov 25.

Supplemental Content

Support Center